Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_assertion type Assertion NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_head.
- NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_assertion description "[Exploring N(1)-p-fluorobenzyl-cymserine as an inhibitor of 5-lipoxygenase as a candidate for type 2 diabetes and neurodegenerative disorder treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_provenance.
- NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_assertion evidence source_evidence_literature NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_provenance.
- NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_assertion SIO_000772 24059322 NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_provenance.
- NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_assertion wasDerivedFrom befree-2016 NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_provenance.
- NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_assertion wasGeneratedBy ECO_0000203 NP1112850.RAHw2hXgIZITZDGKg4SG2GI5JtSHFrSVhcrhIq5rWhlkc130_provenance.